domingo, 13 de marzo de 2016

Should you have the PSA test or not?

Harvard Health Publications
Harvard Health Publications

Could you suffer complications from prostate treatments you never needed?

Four of the scariest words a man can hear are: “You have prostate cancer.” Prostate cancer is the second most commonly diagnosed cancer in American men and the second-leading cause of cancer death.
Sometimes the side effects of treatment, which include erectile dysfunction and incontinence, are worse than the disease.
That's because some prostate cancers found using today's high-tech diagnostic techniques would never have caused any health problems or shortened life. That's one reason many doctors are advising men not to have a routine blood test for prostate-specific antigen (PSA) to detect early prostate cancer. How do you decide what’s best for your health?
Check out Harvard Medical School’s 2016 Annual Report on Prostate Diseases.
This potentially lifesaving report helps you understand why experts are now saying if you don’t have symptoms, don’t get a PSA test. It brings you the latest news on every major prostate disease, from prostate cancer to benign prostatic enlargement (also called BPH) to acute and chronic prostatitis.Click here to discover:
  • The prostate medication that increases your risk for cancer
  • How to lower your risk of BPH by 25%
  • The improved PSA test that saves 20% of men from needing to have a biopsy
  • How to lower your risk of prostate cancer by nearly 30%
  • 2 foods that may increase your risk of prostate cancer — and the ones that help prevent it
  • An effective prostate cancer treatment without risk of erectile dysfunction
  • 5 new medications that can help men with late-stage cancer.
Plus, you’ll get a Special Bonus Section on biomarkers — the future of detecting and treating prostate cancer! You’ll read about a urine-based biomarker that could prevent you from undergoing unnecessary surgery, an FDA-approved test that can help determine if your cancer is high-risk, and even a genetic test that accurately rules out prostate cancer 90% of the time!
Harvard Medical School’s 2016 Annual Report on Prostate Diseases is a must-have for all men and the people who love them. That’s why we’re offering it to you right now at 50% OFF the cover price.
Read More
Marc B. Garnick, M.D.
Editor in Chief, 2016 Annual Report on Prostate Diseases
Gorman Brothers Professor of Medicine, Harvard Medical School
2016 Annual Report on Prostate Diseases
The 2016 Annual Report on Prostate Diseases includes:
Monitoring prostate health
Prostate cancer
An international perspective
Prostate enlargement (benign prostatic hyperplasia)
Inflammation of the prostate (prostatitis)
Erectile dysfunction and urinary incontinence
And so much more!
Read More

No hay comentarios:

Publicar un comentario